Back to Journals » International Journal of Nanomedicine » Volume 18

Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN [Retraction]

Authors Ou L, Lin H, Song Y, Tan G, Gui X, Li J, Chen X, Deng Z, Lin S

Received 14 June 2023

Accepted for publication 14 June 2023

Published 15 June 2023 Volume 2023:18 Pages 3283—3284

DOI https://doi.org/10.2147/IJN.S425886



Ou L, Lin H, Song Y, et al. Int J Nanomedicine. 2020;15:5131–5146.

The Editor and Publisher of International Journal of Nanomedicine are retracting the published article. The authors requested to correct the image used for Figure 8D, p-PTEN, Inhibitor, however it was found the image had been duplicated with that from Figure 7E, p-PTEN, inhibitor from Ou L, Sun T, Liu M, et al. Efficient miRNA Inhibitor Delivery with Graphene Oxide-Polyethylenimine to Inhibit Oral Squamous Cell Carcinoma. Int J Nanomedicine. 2020;15:1569–1583. https://doi.org/10.2147/IJN.S220057.

The authors cooperated with our queries and provided some data from their study, but they were unable to provide a satisfactory explanation for the image duplication. As the findings could not be adequately verified the Editor and Publisher made the decision to retract the article. The authors did not agree with this decision.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.